Literature DB >> 30067922

A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.

Wiebke Fenske1, Julie Refardt1, Irina Chifu1, Ingeborg Schnyder1, Bettina Winzeler1, Juliana Drummond1, Antônio Ribeiro-Oliveira1, Tilman Drescher1, Stefan Bilz1, Deborah R Vogt1, Uwe Malzahn1, Matthias Kroiss1, Emanuel Christ1, Christoph Henzen1, Stefan Fischli1, Anke Tönjes1, Beat Mueller1, Jochen Schopohl1, Jörg Flitsch1, Georg Brabant1, Martin Fassnacht1, Mirjam Christ-Crain1.   

Abstract

BACKGROUND: The indirect water-deprivation test is the current reference standard for the diagnosis of diabetes insipidus. However, it is technically cumbersome to administer, and the results are often inaccurate. The current study compared the indirect water-deprivation test with direct detection of plasma copeptin, a precursor-derived surrogate of arginine vasopressin.
METHODS: From 2013 to 2017, we recruited 156 patients with hypotonic polyuria at 11 medical centers to undergo both water-deprivation and hypertonic saline infusion tests. In the latter test, plasma copeptin was measured when the plasma sodium level had increased to at least 150 mmol per liter after infusion of hypertonic saline. The primary outcome was the overall diagnostic accuracy of each test as compared with the final reference diagnosis, which was determined on the basis of medical history, test results, and treatment response, with copeptin levels masked.
RESULTS: A total of 144 patients underwent both tests. The final diagnosis was primary polydipsia in 82 patients (57%), central diabetes insipidus in 59 (41%), and nephrogenic diabetes insipidus in 3 (2%). Overall, among the 141 patients included in the analysis, the indirect water-deprivation test determined the correct diagnosis in 108 patients (diagnostic accuracy, 76.6%; 95% confidence interval [CI], 68.9 to 83.2), and the hypertonic saline infusion test (with a copeptin cutoff level of >4.9 pmol per liter) determined the correct diagnosis in 136 patients (96.5%; 95% CI, 92.1 to 98.6; P<0.001). The indirect water-deprivation test correctly distinguished primary polydipsia from partial central diabetes insipidus in 77 of 105 patients (73.3%; 95% CI, 63.9 to 81.2), and the hypertonic saline infusion test distinguished between the two conditions in 99 of 104 patients (95.2%; 95% CI, 89.4 to 98.1; adjusted P<0.001). One serious adverse event (desmopressin-induced hyponatremia that resulted in hospitalization) occurred during the water-deprivation test.
CONCLUSIONS: The direct measurement of hypertonic saline-stimulated plasma copeptin had greater diagnostic accuracy than the water-deprivation test in patients with hypotonic polyuria. (Funded by the Swiss National Foundation and others; ClinicalTrials.gov number, NCT01940614 .).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30067922     DOI: 10.1056/NEJMoa1803760

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  35 in total

Review 1.  Copeptin in the differential diagnosis of hypotonic polyuria.

Authors:  M Christ-Crain; W K Fenske
Journal:  J Endocrinol Invest       Date:  2019-07-31       Impact factor: 4.256

2.  A "Set Point" for Water Homeostasis Disturbed with Altered Kidney Transplantation Outcome.

Authors:  Daniel G Bichet
Journal:  J Am Soc Nephrol       Date:  2019-06-19       Impact factor: 10.121

3.  Hypernatremia.

Authors:  Qi Qian
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-06       Impact factor: 8.237

4.  Changing the diagnostic approach to diabetes insipidus: role of copeptin.

Authors:  Anna Grandone; Pierluigi Marzuillo; Giuseppa Patti; Silverio Perrotta; Mohamad Maghnie
Journal:  Ann Transl Med       Date:  2019-12

Review 5.  Vasopressin and Copeptin in health and disease.

Authors:  Mirjam Christ-Crain
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

6.  Serum copeptin and NT-proBNP is associated with central aortic stiffness and flow hemodynamics in adolescents with type 1 diabetes: A pilot study.

Authors:  Isabella Melena; Petter Bjornstad; Michal Schäfer; Kendall S Hunter; Alex J Barker; Amy Baumgartner; Linh Chung; Pattara Wiromrat; Uyen Truong; Jane E B Reusch; Kristen J Nadeau
Journal:  J Diabetes Complications       Date:  2021-02-06       Impact factor: 2.852

7.  Usefulness of non-stimulated copeptin in the diagnosis of diabetes insipidus after pituitary surgery.

Authors:  E Ferrante; A Cremaschi; A L Serban; R Indirli; G Grassi; M Locatelli; M Arosio; G Mantovani
Journal:  J Endocrinol Invest       Date:  2021-02-20       Impact factor: 4.256

8.  Incidence of hyperkalemia during hypertonic saline test for the diagnosis of diabetes insipidus.

Authors:  Laura Potasso; Julie Refardt; Irina Chifu; Martin Fassnacht; Wiebke Kristin Fenske; Mirjam Christ-Crain
Journal:  Endocr Connect       Date:  2021-04       Impact factor: 3.335

9.  Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome.

Authors:  Clara Odilia Sailer; Julie Refardt; Claudine Angela Blum; Ingeborg Schnyder; Jose Alberto Molina-Tijeras; Wiebke Fenske; Mirjam Christ-Crain
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

10.  Synchronous pituitary and pineal gland lesions presenting with panhypopituitarism in a patient with widespread colorectal cancer: a case report.

Authors:  Tristan Struja; Joël Capraro
Journal:  Oxf Med Case Reports       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.